These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26872563)

  • 21. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
    Gordon LG; Rowell D
    Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Face and Scalp Basal Cell Carcinoma Treatment: A Review of the Literature.
    Bernardini N; Skroza N; Zuber S; Tolino E; Balduzzi V; Mambrin A; Marchesiello A; Anzalone A; Colapietra D; Proietti I; Potenza C
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):22-27. PubMed ID: 31032787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging trends in the treatment of advanced basal cell carcinoma.
    Migden MR; Chang ALS; Dirix L; Stratigos AJ; Lear JT
    Cancer Treat Rev; 2018 Mar; 64():1-10. PubMed ID: 29407368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014.
    Migden M; Xie J; Wei J; Tang W; Herrera V; Palmer JB
    J Am Acad Dermatol; 2017 Jul; 77(1):55-62.e3. PubMed ID: 28392293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of inoperable advanced basal cell carcinoma: the economic, physical, and psychological burden of the disease.
    Haves AW; Schaffer PR; Carucci JA
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s151-3. PubMed ID: 24085061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to management of giant basal cell carcinomas.
    Mott SE; Hunter WJ; Silva E; Huerter CJ
    Cutis; 2017 May; 99(5):356-362. PubMed ID: 28632797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
    Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.
    Chang AL; Arron ST; Migden MR; Solomon JA; Yoo S; Day BM; McKenna EF; Sekulic A
    Orphanet J Rare Dis; 2016 Sep; 11(1):120. PubMed ID: 27581207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.
    Correia de Sá TR; Silva R; Lopes JM
    Future Oncol; 2015 Nov; 11(22):3023-38. PubMed ID: 26449265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal cell carcinoma.
    Gupta AK; Daigle D; Martin G
    Skinmed; 2014; 12(1):33-8; quiz 38. PubMed ID: 24720082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal Cell Carcinoma Review.
    Kim DP; Kus KJB; Ruiz E
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):13-24. PubMed ID: 30497670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
    Sekulic A; Migden MR; Lewis K; Hainsworth JD; Solomon JA; Yoo S; Arron ST; Friedlander PA; Marmur E; Rudin CM; Chang AL; Dirix L; Hou J; Yue H; Hauschild A;
    J Am Acad Dermatol; 2015 Jun; 72(6):1021-6.e8. PubMed ID: 25981002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of basal cell carcinoma].
    Schmitz L; Dirschka T
    Hautarzt; 2016 Jun; 67(6):483-99. PubMed ID: 27206448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermoscopy in the diagnosis and management of basal cell carcinoma.
    Lallas A; Apalla Z; Ioannides D; Argenziano G; Castagnetti F; Moscarella E; Longo C; Palmieri T; Ramundo D; Zalaudek I
    Future Oncol; 2015 Nov; 11(22):2975-84. PubMed ID: 26450622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal cell carcinoma: when to treat it yourself, and when to refer.
    Pariser DM; Phillips PK
    Geriatrics; 1994 Mar; 49(3):39-44. PubMed ID: 8125351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update of the European guidelines for basal cell carcinoma management.
    Trakatelli M; Morton C; Nagore E; Ulrich C; Del Marmol V; Peris K; Basset-Seguin N;
    Eur J Dermatol; 2014; 24(3):312-29. PubMed ID: 24723647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread.
    Hoorens I; Batteauw A; Van Maele G; Lapiere K; Boone B; Ongenae K
    Br J Dermatol; 2016 Apr; 174(4):847-52. PubMed ID: 26595159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced, neglected basal cell carcinoma.
    Wiznia LE; Shanley KM; Federman DG
    South Med J; 2014 Apr; 107(4):242-5. PubMed ID: 24937518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
    Caekelbergh K; Annemans L; Lambert J; Roelandts R
    Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.
    van Egmond S; van Vliet ED; Wakkee M; Hollestein LM; Pouwels XGLV; Koffijberg H; Misirli Y; Bakkum RSLA; Bastiaens MT; Kukutsch NA; Oosting AJ; Plasmeijer EI; van Rengen A; de Roos KP; Nijsten TEC; de Vries E; de Bekker-Grob EW
    PLoS One; 2022; 17(1):e0260978. PubMed ID: 35073333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.